Subcutaneous spesolimab for GPP flare prevention

Presented By

Prof. Bruce Strober, Yale University School of Medicine, CT, USA

Trial

Effisayil 2

Conference

WCD 2023

31 August, 2023 15:32

Rapid pustule and skin clearance with IL-36 receptor inhibitor spesolimab

Presented By

Prof. Hervé Bachelez, Hôpital Saint-Louis, France

Trial

Phase 2, Effisayil 1

Conference

WPPAC 2021

17 September, 2021 11:04